These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24140176)

  • 1. Expression of MDR1 and MDR3 gene products in paclitaxel-, doxorubicin- and vincristine-resistant cell lines.
    Januchowski R; Wojtowicz K; Andrzejewska M; Zabel M
    Biomed Pharmacother; 2014 Feb; 68(1):111-7. PubMed ID: 24140176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversal effect of MDR1 and MDR3 gene silencing on resistance of A2780/taxol cells to paclitaxel].
    Xiao L; Gao R; Lu S; Lu MS; Liang ML; Ren LR; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):412-6. PubMed ID: 17697605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line.
    Zhou J; Cheng SC; Luo D; Xie Y
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1237-42. PubMed ID: 11162660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD; Işeri OD; Gündüz U
    Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor.
    Hasegawa K; Ishikawa K; Kawai S; Torii Y; Kawamura K; Kato R; Tsukada K; Udagawa Y
    Oncol Rep; 2013 Dec; 30(6):2937-44. PubMed ID: 24100466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer drugs induce mdr1 gene expression in recurrent ovarian cancer.
    Hille S; Rein DT; Riffelmann M; Neumann R; Sartorius J; Pfützner A; Kurbacher CM; Schöndorf T; Breidenbach M
    Anticancer Drugs; 2006 Oct; 17(9):1041-4. PubMed ID: 17001177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.
    Duan Z; Choy E; Jimeno JM; Cuevas Cdel M; Mankin HJ; Hornicek FJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1121-9. PubMed ID: 18828019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
    Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
    Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
    Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM; Levy SB
    Oncol Res; 1997; 9(4):183-91. PubMed ID: 9268989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
    Tsang WP; Kwok TT
    Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
    Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
    J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
    Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATPase activity of nucleotide binding domains of human MDR3 in the context of MDR1.
    Ishigami M; Tominaga Y; Nagao K; Kimura Y; Matsuo M; Kioka N; Ueda K
    Biochim Biophys Acta; 2013 Apr; 1831(4):683-90. PubMed ID: 23305784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of P-glycoprotein and glutathione S-transferase-pi mediated resistance by fluoxetine in MCF-7/ADM cells.
    Zhang Y; Zhou T; Duan J; Xiao Z; Li G; Xu F
    Biomed Pharmacother; 2013 Oct; 67(8):757-62. PubMed ID: 23731711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR.
    Zhang KG; Qin CY; Wang HQ; Wang JX; Wang QM
    Hepatogastroenterology; 2012; 59(120):2672-6. PubMed ID: 23178631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and reversal of MDR1/P-gp in pancreatic cancer chemotherapy].
    Guo JC; Zhao YP; Liao Q; Zhu Y
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(21):1488-90. PubMed ID: 18275717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells.
    Kars MD; Işeri OD; Gündüz U
    Eur J Pharmacol; 2011 Apr; 657(1-3):4-9. PubMed ID: 21320484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.